
Discure Technologies
Develops minimally invasive bioelectronic solutions for treating low back pain and spinal degeneration.
About
Discure Technologies develops a minimally invasive, implantable device designed to treat and reverse degenerative disc disease by restoring the disc's healthy fluid dynamics. This approach aims to restore cushioning, stability, revive disc cells, and accelerate healing to reduce pain and restore function for individuals suffering from back pain. The company serves patients experiencing back pain due to disc degeneration and collaborates with hospitals, universities, and healthcare companies.
Key facts
At-a-glance profile data
- Website
- discuremd.com
- Headquarters
- Tel Aviv, Israel
- Founded
- 2021
- Employees
- 12
- Total funding
- $11M (Series A)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 10 Sept 2024 | Series A | $11M | Sanara Ventures, BOLD Capital Partners |
Tech stack
Detected on discuremd.com, last scanned 4 Sept 2026. Run your own scan
- Compliance
- GDPR
- Frontend
- jQuery, Bootstrap
- Analytics
- Google Analytics 4
- CMS / Builders
- WordPress
- Email provider
- Microsoft 365
- Video / media
- Vimeo
Frequently asked
How much funding has Discure Technologies raised?
Discure Technologies has raised a total of $11M in funding. The most recent round on record is Series A.
How many employees does Discure Technologies have?
Discure Technologies has approximately 12 people on record.